Langvarig suppression af mavesyresekretion ved H2- antagonister eller protonpumpe- hæmmere (fx famotidin og omeprazol) vil sandsynligvis reducere eksponeringen af dasatinib.
Long-term suppression of gastric acid secretion by H2 antagonists or proton pump inhibitors (e. g. famotidine and omeprazole) is likely to reduce dasatinib exposure.